Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events

NCT04279470 is registered in ClinicalTrials.gov with Groupe Hospitalier Pitie-Salpetriere as lead sponsor.

NCT NCT04279470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04279470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events
Lead sponsor
Groupe Hospitalier Pitie-Salpetriere
Phase
Observational
Overall status
Completed
Start date
January 1, 2019
Completion date
April 8, 2023
Enrollment
100,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug reactions, cancer